Immuneering (IMRX) Non-Current Assets (2020 - 2026)

Immuneering's Non-Current Assets history runs 7 years deep, the most recent figure standing at $53.4 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 328.06% year-over-year to $53.4 million in Q1 2026; TTM through Mar 2026 was $133.4 million, a 155.11% increase from a year earlier, with the FY2025 full-year figure at $55.7 million, up 324.62% from the prior year.
• Non-Current Assets slipped to $53.4 million in Q1 2026 per IMRX's latest filing, from $55.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $55.7 million in Q4 2025 and bottomed at $12.0 million in Q3 2025.
• The 5-year median for Non-Current Assets is $13.4 million (2023), against an average of $18.0 million.
• Across the five-year window, Non-Current Assets soared 702.36% in 2022 and dropped 10.1% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $13.6 million in 2022, then fell by 0.88% to $13.5 million in 2023, then retreated by 2.77% to $13.1 million in 2024, then surged by 324.62% to $55.7 million in 2025, then dropped by 4.2% to $53.4 million in 2026.
• Per Business Quant, the three latest IMRX Non-Current Assets figures stand at $53.4 million (Q1 2026), $55.7 million (Q4 2025), and $12.0 million (Q3 2025).